Lisette Okkels Jensen

Medicine & Life Sciences

1. Stents 100%
2. Percutaneous Coronary Intervention 90%
3. ST Elevation Myocardial Infarction 80%
4. Sirolimus 57%
5. Myocardial Infarction 52%
6. Cardiogenic Shock 47%
7. Drug-Eluting Stents 38%
8. Denmark 30%
9. Coronary Artery Disease 27%
10. Registries 27%
11. Mortality 26%
12. zotarolimus 26%
13. Polymers 24%
14. Everolimus 24%
15. Thrombosis 20%
16. Coronary Angiography 19%
17. Optical Coherence Tomography 19%
18. Confidence Intervals 18%
19. Diabetes Mellitus 17%
20. Non-ST Elevated Myocardial Infarction 15%
21. Reperfusion 15%
22. Randomized Controlled Trials 15%
23. Equivalence Trials 15%
24. Metals 14%
25. BES 13%
26. Coronary Vessels 12%
27. Angiography 11%
28. Heart 11%
29. Acute Coronary Syndrome 11%
30. Pandemics 9%
31. Therapeutics 8%
32. Incidence 8%
33. Out-of-Hospital Cardiac Arrest 8%
34. Stroke 8%
35. Safety 8%
36. Myocardial Ischemia 8%
37. Stable Angina 8%
38. Paclitaxel 8%
39. Ischemic Postconditioning 7%
40. Computed Tomography Angiography 7%
41. Cohort Studies 7%
42. Population 7%
43. Atrial Fibrillation 7%
44. Angioplasty 6%
45. Perfusion 6%
46. Clopidogrel 6%
47. Multicenter Studies 6%
48. Chest Pain 6%
49. Cause of Death 6%
50. Pathologic Constriction 6%